Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Product Labeling topic
No spam. Unsubscribe anytime.
Senator Toews presents bill requiring labeling for products developed with fetal tissue; committee sends it to print
Summary
RS 33394, presented by Senator Ben Toews, would require labeling for products sold in Idaho that contain or were developed using human fetal tissue; the committee voted to send the bill to print with one recorded nay.
Senator Ben Toews (Idaho District 4) presented RS 33394 to the Senate Judiciary & Rules Committee as a transparency measure aimed at labeling products developed with human fetal tissue or biological derivatives.
"Any products sold in Idaho that contained fetal tissue or that had been developed or produced utilizing fetal tissue," Toews said, describing the scope of the bill. Senator Ricks asked whether specific incidents motivated the proposal; Toews pointed to concerns in the medical and cosmetic industries where transparency would be helpful.
After discussion, Senator Ricks moved to send RS 33394 to print and Senator Foreman seconded. The motion carried by voice vote; Senator Wintrow requested to be recorded as voting nay. The minutes do not record a roll-call tally beyond that notation.
The bill, as presented, focuses on disclosures and labeling rather than bans or restrictions; the committee elected to advance it to printing for further drafting and referral.
